CitationCount for TroFuse-011 study design: sacituzumab tirumotecan with or without pembrolizumab for advanced triple-negative breast cancer with PD-L1 CPS <10 Global Citation Count uri icon

has global count value

  • 1

has global count date

  • October 24, 2026 1:32 AM